CoChat

Japanese Clinical Practice Guideline for Diabetes 2016

Open access
Haneda, Masakazu, Noda, Mitsuhiko, Origasa, Hideki, Noto, Hiroshi, Yabe, Daisuke, Fujita, Yukihiro, Goto, Atsushi, Kondo, Tatsuya, Araki, Eiichi · 2018 · Journal of Diabetes Investigation
Cited by 181

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Abstract

statements were developed separately as general questions and clinical questions based on published clinical evidence as well as expert consensus.This guideline offers key recommendations for clinical practice that are supported by scientific evidence from published studies.Studies of interest were obtained by a systematic search of the English and Japanese literature.The electronic databases used for literature search included at least MED-LINE and the Japanese ICHUSHI database (http://www.jamas. or.jp/).The search strategies used were developed by each author.The studies of interest were critically appraised by the authors to determine their relevance to the statements of the guideline and whether they were worth citing.Each study was assigned a level of evidence using the approach described in Table 1.Each statement for the CQs was assigned a grade of recommendation based on the total body of evidence as well as the risk-benefit balance, value, patient preferences, cost, and resources.Statements were graded as A (strongly recommended) or B (recommended), followed by the agreement rate among authors.Grade A or B by consensus reflects a recommendation based solely on the consensus of professionals and indicates that the recommendation was adopted with a ≥70% agreement rate among the authors.A summary table, including an identifier, the research design, the level of evidence and population, methods, and results of the cited articles was attached at the end of each chapter in the original Japanese version (The Japan Diabetes Society: Japanese Clinical Practice Guideline for diabetes 2016.Tokyo: Nankodo, 2016.).Scientific reports supporting a statement were cited as 'References' and additional guidelines or review articles were listed as 'Additional reference materials'.The guideline will be reviewed every 3 years, as there will be considerable advances in clinical research and practice that will require a re-evaluation of the scientific evidence as it becomes available.All potential conflicts of interest were disclosed by authors. GUIDELINE FOR THE DIAGNOSIS OF DIABETES MELLITUSQ1-1 How is diabetes diagnosed?(Figure 1)• The diagnosis of diabetes mellitus should be as comprehensive as possible.It is confirmed by the presence of chronic hyperglycemia, and by the presence of other factors, such as associated symptoms, clinical laboratory findings, a family history of diabetes, and the patient's body weight history 1-5 .For the diagnosis of diabetes, either of the following approaches is to be followed: ① Two assessments of the diabetic type in each patient (one blood glucose test is mandatory).② One assessment of the diabetic type (with mandatory blood glucose testing) along with the presence of chronic hyperglycemic symptoms*.(*typical symptoms of chronic hyperglycemia (e.g., dry mouth, polyposia, polyuria, body weight loss, or diabetic retinopathy).③ Evidence of a prior diagnosis of 'diabetes'.Q1-2 How is hyperglycemia assessed?(Figure 2)• Patients are to be classified into the normal type, borderline type, or diabetic type, based on the combination of fasting and 2-h post-75 g oral glucose tolerance test (OGTT) glucose values.• Patients whose fasting glucose values are 100-109 mg/dL (5.6-6.1 mmol/L) are classified into the 'high normal' category as part of the normal type 6 .• The OGTT is to be proactively considered in high-risk individuals (i.e., those who are suspected to have diabetes or the borderline type, those whose fasting glucose values are shown to be 'high-normal', those with HbA1c values of ≥5.6%, those with obesity or dyslipidemia, and those with a strong family history of diabetes 5 ).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdi.12810

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 98 references

Research works printed but not linked: 218

  1. Kosaka K, 1982, Report of committee on the classification and diagnostic criteria of diabetes mellitus, J Jpn Diabetes Soc, 25, 859
  2. World Health Organization, 1999, Report of a WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus
  3. Kuzuya T, 1999, Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus, J Jpn Diabetes Soc, 42, 385
  4. Kadowaki T, 2008, Report of the Japan Diabetes Society's Committee on the diagnostic criteria for diabetes mellitus and glucose metabolism disorder―a new category of fasting plasma glucose values: “high‐normal”, J Jpn Diabetes Soc, 51, 281
  5. 10.1007/s13340-015-0210-6 · DOI
  6. 10.1111/jdi.12024 · DOI · Paper page
  7. 10.2169/naika.102.1829 · DOI
  8. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  9. Nakagawa Y, 2014, Impact of the duration of diabetes and frequency of counseling on the effectiveness of dietitian‐led medical nutrition therapy in patients with type 2 diabetes, J Jpn Diabetes Soc, 57, 813
  10. 10.1161/CIRCULATIONAHA.109.192521 · DOI · Paper page
  11. 10.1016/j.puhe.2007.02.014 · DOI · Paper page
  12. 10.1007/BF03262312 · DOI · Paper page
  13. 10.1371/journal.pone.0058861 · DOI · Paper page
  14. 10.2337/dc14-1140 · DOI · Paper page
  15. 10.1111/j.1600-051X.1988.tb01003.x · DOI · Paper page
  16. Bennett WL, 2011, AHRQ Comparative Effectiveness Reviews. Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update
  17. Kaku K, 2006, Melbin observational research (MORE) study of metformin therapy in patients with type 2 diabetes mellitus, J Jpn Diabetes Soc, 49, 325
  18. 10.1001/archinte.168.8.820 · DOI · Paper page
  19. 10.1503/cmaj.080486 · DOI · Paper page
  20. 10.1016/S0140-6736(09)60953-3 · DOI · Paper page
  21. 10.1007/s00125-012-2668-0 · DOI · Paper page
  22. 10.1001/jama.299.13.1561 · DOI · Paper page
  23. 10.1007/s13340-011-0022-2 · DOI
  24. 10.1111/dom.12235 · DOI
  25. 10.1111/j.1463-1326.2007.00744.x · DOI · Paper page
  26. Iwakura T, 2010, A case of severe hypoglycemia induced by sitagliptin added to ongoing glimepiride therapy in patients with type 2 diabetes, J Jpn Diabetes Soc, 53, 505
  27. 10.1007/s13340-013-0109-z · DOI
  28. 10.1111/dom.12176 · DOI · Paper page
  29. 10.1111/j.1463-1326.2009.01194.x · DOI · Paper page
  30. 10.1111/j.1463-1326.2012.01618.x · DOI · Paper page
  31. 10.1111/dom.12244 · DOI · Paper page
  32. 10.1111/dom.12189 · DOI · Paper page
  33. 10.1046/j.1464-5491.2001.00582.x · DOI · Paper page
  34. 10.2337/diacare.22.1.119 · DOI · Paper page
  35. 10.1046/j.1463-1326.2001.00141.x · DOI · Paper page
  36. 10.1016/S0149-2918(00)83039-8 · DOI · Paper page
  37. 10.1111/j.1463-1326.2010.01326.x · DOI · Paper page
  38. 10.1185/03007990802711024 · DOI · Paper page
  39. 10.1111/j.1464-5491.2009.02816.x · DOI
  40. 10.1111/dom.12229 · DOI · Paper page
  41. 10.1111/ijcp.12322 · DOI · Paper page
  42. Takahashi Y, 1998, Clinical features of eighty‐six diabetic patients with post‐treatment painful neuropathy, J Jpn Diabetes Soc, 41, 165
  43. 10.7326/0003-4819-128-3-199802010-00001 · DOI · Paper page
  44. 10.1056/NEJM199309303291401 · DOI · Paper page
  45. Lawson ML, 1999, Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta‐analysis, Diabetes Care, 22, B35
  46. 10.1016/0168-8227(95)01064-K · DOI · Paper page
  47. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  48. Shichiri M, 2000, Long‐term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21
  49. 10.1056/NEJMoa075392 · DOI · Paper page
  50. 10.1111/j.1463-1326.2008.00915.x · DOI · Paper page
  51. 10.1016/S0168-8227(98)00003-5 · DOI
  52. 10.2337/diacare.25.2.330 · DOI · Paper page
  53. 10.1007/s00592-006-0231-5 · DOI
  54. 10.2337/diacare.24.10.1844 · DOI
  55. 10.2169/internalmedicine.46.0415 · DOI
  56. 10.7326/0003-4819-131-3-199908030-00004 · DOI · Paper page
  57. 10.1002/(SICI)1096-9136(1998120)15:12<997::AID-DIA716>3.0.CO;2-B · DOI · Paper page
  58. 10.1016/S0149-2918(00)90005-5 · DOI
  59. Juntti‐Berggren L, 2000, Influence of acarbose on post‐prandial insulin requirements in patients with type 1 diabetes, Diabetes Nutr Metab, 13, 7
  60. Han A, 2004, Effect of combination therapy of premixtured 50 R and voglibose in patients with type 2 diabetes, J Jpn Diabetes Soc, 47, 137
  61. 10.1056/NEJM199803263381302 · DOI · Paper page
  62. 10.1016/j.clinthera.2005.05.005 · DOI
  63. 10.1016/j.diabres.2007.04.012 · DOI
  64. 10.2337/diacare.24.7.1226 · DOI · Paper page
  65. 10.1016/S0140-6736(14)61335-0 · DOI · Paper page
  66. 10.1016/j.pec.2009.09.033 · DOI · Paper page
  67. 10.1056/NEJM199309303291401 · DOI · Paper page
  68. 10.1016/S0002-9343(01)00742-2 · DOI · Paper page
  69. 10.2337/diacare.28.2.278 · DOI · Paper page
  70. 10.1186/1471-244X-13-260 · DOI · Paper page
  71. 10.1001/archopht.1989.01070010243030 · DOI · Paper page
  72. 10.1001/archopht.1989.01070010250031 · DOI · Paper page
  73. 10.1016/S0140-6736(03)12267-2 · DOI · Paper page
  74. 10.1111/j.1464-5491.2009.02820.x · DOI · Paper page
  75. 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P · DOI · Paper page
  76. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  77. 10.1001/archopht.122.11.1631 · DOI · Paper page
  78. 10.1016/S0140-6736(07)61607-9 · DOI · Paper page
  79. 10.1016/S0161-6420(78)35693-1 · DOI · Paper page
  80. Evans JR, 2014, Laser photocoagulation for proliferative diabetic retinopathy, Cochrane Database Syst Rev, 11, CD011234
  81. 10.1007/BF00137653 · doi:10.1007/bf00137653
  82. 10.2337/diacare.25.5.859 · DOI · Paper page
  83. 10.1161/01.STR.0000254547.91276.50 · DOI · Paper page
  84. 10.2337/dc12-1311 · DOI · Paper page
  85. 10.1016/j.ophtha.2012.08.029 · DOI
  86. 10.1007/s00125-010-2025-0 · DOI
  87. 10.1053/j.ajkd.2008.12.034 · DOI · Paper page
  88. 10.1053/j.ajkd.2012.07.007 · DOI · Paper page
  89. 10.1016/0168-8227(95)01064-K · DOI · Paper page
  90. 10.1001/archinternmed.2011.537 · DOI · Paper page
  91. 10.1136/bmj.317.7160.703 · DOI · Paper page
  92. 10.1111/j.1463-1326.2012.01566.x · DOI
  93. 10.1016/j.diabres.2004.02.015 · DOI
  94. 10.1016/S0140-6736(05)67814-2 · DOI · Paper page
  95. Suckling RJ, 2010, Altered dietary salt intake for preventing and treating diabetic kidney disease, Cochrane Database Syst Rev, CD006763
  96. 10.2337/diacare.24.1.111 · DOI · Paper page
  97. 10.1046/j.1523-1755.2002.00421.x · DOI · Paper page
  98. 10.1007/s00125-009-1467-8 · DOI · Paper page
  99. 10.1159/000190270 · DOI · Paper page
  100. 10.1053/j.ajkd.2012.07.007 · DOI · Paper page
  101. Hotta N, 1996, Diabetic Neuropathy, 145
  102. 10.2337/diacare.28.4.956 · DOI · Paper page
  103. 10.1056/NEJM199309303291401 · DOI · Paper page
  104. 10.1016/0168-8227(95)01064-K · DOI · Paper page
  105. 10.1212/WNL.37.4.589 · DOI · Paper page
  106. 10.2337/dc07-2105 · DOI · Paper page
  107. 10.1111/j.1464-5491.2010.03152.x · DOI · Paper page
  108. 10.1111/j.1526-4637.2007.00305.x · DOI
  109. 10.1111/j.2040-1124.2010.00073.x · DOI · Paper page
  110. 10.2337/dc10-0456 · DOI
  111. Japanese Study Group on Diabetic Neuropathy, 2012, Simplified diagnostic criteria and clinical staging of diabetic polyneuropathy, Peripheral Nerve, 23, 109
  112. 10.1016/S1067-2516(07)60001-5 · DOI · Paper page
  113. 10.2337/dc07-1178 · DOI · Paper page
  114. 10.1016/0002-9610(89)90183-9 · DOI · Paper page
  115. 10.1136/bmj.321.7258.405 · DOI · Paper page
  116. Edmonds ME, 1986, Improved survival of the diabetic foot: the role of a specialized foot clinic, Q J Med, 60, 763
  117. 10.1016/j.jacc.2011.08.023 · DOI · Paper page
  118. 10.1093/cid/cis346 · DOI · Paper page
  119. 10.1002/dmrr.2299 · DOI · Paper page
  120. 10.1007/s001250051459 · DOI · Paper page
  121. 10.1016/S1262-3636(07)70193-3 · DOI
  122. 10.1016/j.jdiacomp.2007.06.006 · DOI
  123. 10.2337/diacare.27.6.1286 · doi:10.2337/diacare.27.6.1286
  124. 10.1007/s00125-012-2673-3 · DOI · Paper page
  125. 10.2337/dc13-1545 · DOI · Paper page
  126. 10.1136/bmj.321.7258.405 · DOI · Paper page
  127. 10.2165/11638240-000000000-00000 · DOI
  128. 10.1371/journal.pone.0111247 · DOI
  129. 10.1007/s11606-011-1757-y · DOI
  130. Takahashi K, 2001, Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus, J Int Acad Periodontol, 3, 104
  131. 10.1177/0022034511431583 · DOI · Paper page
  132. 10.1111/jdi.12026 · DOI
  133. 10.2337/dc08-0026 · DOI · Paper page
  134. 10.1902/jop.2013.1340013 · DOI · Paper page
  135. 10.1902/jop.2013.1340017 · DOI
  136. Matsuzawa Y, 2006, Guidelines for the management of obesity disease 2006, Obesity Research, 12, 1
  137. Saito Y, 2011, Diagnostic criteria for obesity disease 2011, Obesity Research, 17, 1
  138. 10.1093/pubmed/fdt061 · DOI · Paper page
  139. 10.1007/s11695-013-1160-3 · DOI · Paper page
  140. 10.2169/naika.94.794 · DOI · Paper page
  141. 10.2337/dc16-S012 · DOI
  142. 10.1161/CIRCULATIONAHA.110.016337 · DOI · Paper page
  143. 10.1111/j.1751-7176.2012.00648.x · DOI
  144. 10.1001/jama.2010.884 · DOI · Paper page
  145. 10.1016/S0272-6386(99)70036-3 · DOI · Paper page
  146. 10.1016/j.diabres.2013.07.009 · DOI
  147. 10.1161/CIRCULATIONAHA.113.002529 · DOI · Paper page
  148. 10.1186/1475-2840-11-109 · DOI
  149. 10.2337/diacare.22.6.889 · DOI · Paper page
  150. Hartweg J, 2008, Omega‐3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus, Cochrane Database Syst Rev, CD003205
  151. 10.1016/j.diabres.2012.10.004 · DOI · Paper page
  152. 10.1093/qjmed/94.8.435 · DOI · Paper page
  153. 10.2337/diacare.18.5.631 · DOI · Paper page
  154. Sanaka M, 2006, The allowance for pregnancy of women with diabeticnephropathy, J Jpn Soc Diabetes Pregn, 6, 127
  155. 10.1016/S0140-6736(10)60751-9 · DOI · Paper page
  156. 10.1016/S0002-9378(94)70097-4 · DOI · Paper page
  157. Hiramatsu Y, 2015, The joint committee with the Japan Society of Diabetes and Pregnancy and the Japan Diabetes Society “An abnormal glucose metabolism during pregnancy and the standardization of its diagnostic criteria”, J Jpn Diabetes Soc, 58, 801
  158. 2015, ISPAD Clinical Practice Consensus Guidelines for Pediatric and Adolescent Diabetes 2014
  159. 10.1111/pedi.12182 · DOI
  160. 10.1111/pedi.12186 · DOI · Paper page
  161. 10.1111/pedi.12174 · DOI · Paper page
  162. 10.1111/pedi.12179 · DOI · Paper page
  163. Urakami T, 2012, Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan, Pediatr Endocrinol Rev, 1, 51
  164. 10.1297/cpe.14.65 · DOI
  165. 10.2337/dc07-1785 · DOI · Paper page
  166. 10.1111/pedi.12187 · DOI · Paper page
  167. 10.1111/pedi.12191 · DOI · Paper page
  168. 10.2337/diab.43.8.960 · DOI · Paper page
  169. 10.1111/j.1532-5415.2012.04099.x · DOI · Paper page
  170. 10.1111/j.1463-1326.2012.01583.x · DOI · Paper page
  171. 10.1016/S0140-6736(97)12355-8 · DOI · Paper page
  172. 10.1056/NEJM199804093381506 · DOI · Paper page
  173. 10.1016/j.diabres.2011.09.012 · DOI
  174. 10.2337/dc06-9909 · DOI · Paper page
  175. 10.1056/NEJMra1309483 · DOI · Paper page
  176. 10.2337/dc13-3023 · DOI · Paper page
  177. 10.2337/dc16-S004 · DOI
  178. 10.1056/NEJM199912163412507 · DOI · Paper page
  179. 10.1136/thoraxjnl-2012-203109 · DOI · Paper page
  180. Moberley SA, 2013, Vaccines for preventing pneumococcal infection in adults, Cochrane Database Syst Rev, CD000422
  181. 10.1111/pedi.12193 · DOI
  182. 10.1007/s00125-012-2712-0 · DOI
  183. Sasai H, 2008, [Development of a diabetes risk prediction sheet for specific health guidance], Nihon Koshu Eisei Zasshi, 55, 287
  184. 10.1111/j.1464-5491.2011.03376.x · DOI · Paper page
  185. 10.1093/aje/kws172 · DOI · Paper page
  186. 10.1097/EDE.0b013e31829f6c31 · DOI
  187. 10.1111/obr.12129 · DOI
  188. 10.1093/aje/kwk071 · DOI · Paper page
  189. 10.1001/jama.2008.886 · DOI · Paper page
  190. 10.2337/dc07-0090 · DOI · Paper page
  191. 10.1371/journal.pmed.1001587 · DOI · Paper page
  192. 10.1001/archinternmed.2012.3138 · DOI · Paper page
  193. 10.1016/j.diabres.2004.06.010 · DOI · Paper page
  194. 10.1186/1471-2458-11-40 · DOI · Paper page
  195. 10.1007/s10654-013-9876-x · DOI · Paper page
  196. 10.1111/j.1464-5491.2004.01403.x · DOI · Paper page
  197. Seike N, 2008, Alcohol consumption and risk of type 2 diabetes mellitus in Japanese: a systematic review, Asia Pac J Clin Nutr, 17, 545
  198. 10.1017/S0007114514001329 · DOI · Paper page
  199. 10.7326/0003-4819-152-1-201001050-00005 · DOI · Paper page
  200. 10.1371/journal.pone.0017061 · DOI

200 of 218 shown

Cited by

Metadata

Authors
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E.
Venue
Journal of Diabetes Investigation
Publisher
Wiley
Published
2018-03-26
Volume
9
Issue
3
Pages
657-697
ISSN
  • 2040-1116 (ISSN-L)
  • 2040-1124
OpenAlex
W4211190017
Cited by
181
References
98
FWCI
24.22
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.